BCRX
BioCryst Pharmaceuticals Inc
Price:  
8.78 
USD
Volume:  
2,516,780.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Relative Valuation

-307.8%
Upside

As of 2025-02-13, the Relative Valuation of BioCryst Pharmaceuticals Inc (BCRX) is (18.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.78 USD, the upside of BioCryst Pharmaceuticals Inc based on Relative Valuation is -307.8%.

The range of the Relative Valuation is (19.37) - (20.56) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.5x - 38.8x 27.6x
Forward P/E multiples 32.4x - 34.4x 33.4x
Fair Price (19.37) - (20.56) (18.25)
Upside -320.6% - -334.2% -307.8%
8.78 USD
Stock Price
(18.25) USD
Fair Price

BCRX Relative Valuation - Historical P/E Data

Date P/E
2025-02-12 -14.69
2025-02-11 -15.04
2025-02-10 -14.44
2025-02-07 -14.59
2025-02-06 -14.60
2025-02-05 -14.40
2025-02-04 -13.53
2025-02-03 -12.75
2025-01-31 -13.22
2025-01-30 -13.17
2025-01-29 -13.42
2025-01-28 -13.27
2025-01-27 -13.40
2025-01-24 -12.78
2025-01-23 -12.93
2025-01-22 -12.75
2025-01-21 -12.73
2025-01-17 -12.46
2025-01-16 -11.81
2025-01-15 -12.09
2025-01-14 -12.09
2025-01-13 -13.27
2025-01-10 -12.83
2025-01-08 -13.47
2025-01-07 -13.62
2025-01-06 -13.10
2025-01-03 -12.88
2025-01-02 -13.10
2024-12-31 -12.58
2024-12-30 -12.60
2024-12-27 -12.90
2024-12-26 -12.91
2024-12-24 -12.83
2024-12-23 -13.01
2024-12-20 -12.66
2024-12-19 -12.36
2024-12-18 -12.23
2024-12-17 -12.53
2024-12-16 -12.48
2024-12-13 -12.60
2024-12-12 -12.71
2024-12-11 -13.15
2024-12-10 -13.27
2024-12-09 -12.93
2024-12-06 -12.73
2024-12-05 -13.12
2024-12-04 -12.26
2024-12-03 -12.03
2024-12-02 -12.35
2024-11-29 -12.55